[PDF] Top 20 Prognostic Value of Basic Fibroblast Growth Factor (bFGF) in Lung Cancer: A Systematic Review with Meta-Analysis.

... associated with bFGF expression. However, there was moderate hetero- geneity in the whole group (I 2 = ...source of heterogeneity through sensitivity ...carefully with others, and we inferred ... See full document

... stage of the included patients was not homogeneous: Zhu et ...patients with early-stage disease, and Li et ...ELISA analysis on blood samples; another four studies performed IHC analysis ... See full document

... appears in almost all cases [23,35]. Typically a reactivation of MAPK pathway happens in resistant cases through other mechanisms including RAS or MEK1 mutations, COT overexpression or BRAF ... See full document

... including lung and breast cancer, and found that the propor- tion of cells that expressed ALDH1 was ...subset of the CD133-positive population. ALDH1 expression was the highest in ... See full document

... efficacy of AZD4547 and BGJ398 on FGFR gene–amplified cancers both in vitro and in vivo ...summarized in a published paper ...activity of the FGFR inhibitor AZD4547 in patients ... See full document

... standardization of evaluating vascular invasion and quality control is needed. In addition, an important issue that needs to be taken into account is the type of adjuvant therapy that each patient ... See full document

... production of other cytokines, which prolong and increase inflamma- tion and produce cytotoxic molecules, such as the major basic protein (MBP), the eosinophilic cationic protein (ECP), leukotrienes and the ... See full document

... Corpus luteum is a temporary endocrine gland that regulates either the estrous cycle and pregnancy. It presents extreme dependency on the adequate blood supply. This work aims to evaluate goat corpus luteum (CL) vascular ... See full document

... ment of systemic inflammation in cancer develop- ment and progression ...concentration of acute phase proteins, CRP, fibrinogen, ferritin, albumin and transferrin, or peripheral blood leu- ... See full document

... error in reference ...study of panitumumab with fluorouracil, leucovorin, and irinotecan(FOLFIRI) compared with FOLFIRI alone as second- line treatment in patients with ... See full document

... use in various tumor types and clinical settings ...treatment with anti-PD-L1 antibody ibrutinib (a covalent inhibitor of Bru- ton’s tyrosine kinase) suppresses tumor growth in mouse ... See full document

... prostate cancer [51, 52]. In addition to potential carcinogenic pathways being linked to an increase risk Pca, oxidative stress generated during fat metabolism has been reported to increase the risk for Pca ... See full document

... variety of predictors have been found and applied in the prognosis of various carcinomas, such as TNM stage, genetic factors, and inflammatory ...detected in peripheral blood before ... See full document

... inclusion in this overview, resulting in 13 articles after applying the exclusion criteria, and only 10 of these were used for meta-analysis, adding up to a total of 4831 ... See full document

... present systematic review with meta-analysis shows that the 388 G>A mutation of the SLCO1B1 gene is a risk factor for developing neonatal hyperbilirubinemia in ... See full document

... evaluation of transrectal ultrasound and biopsy of the achievement were made by the same ...way with side region samples and the transition zone with 12 or 14 ...staging with bone ... See full document

... database of the Oslo Breast Cancer Micrometastasis Study (Table ...Out of 377 patients with information of non-surgical treatment, 22% received radiation therapy, 29% post operative ... See full document

... gastric cancer (GC); it has been shown to increase the median overall survival (OS) from ...compared with the best supportive care ...resulted in more modest increases in the median time to ... See full document

... our meta-analysis results. One of the main limitations is the significant heterogeneity between the included ...model with the pooled ...differences in the specific study designs ... See full document

... that in urothelial carcinomas, in most cases, BLCAP protein expression was lost with tumor ...overexpressed in 20% of the cases, independently of the clinicopathological ... See full document